Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.46 EUR | -0.40% |
|
-0.61% | -8.89% |
09/05 | Uniphar says trading in line, reports good start to 2024 | AN |
09/05 | Uniphar Logs Organic Gross Profit Growth in FY23, Affirms FY24 Guidance | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The stock, which is currently worth 2024 to 0.34 times its sales, is clearly overvalued in comparison with peers.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.89% | 720M | C+ | ||
-1.17% | 24.62B | C+ | ||
+15.06% | 8.75B | B | ||
+1.96% | 8.35B | C | ||
-31.14% | 7.1B | B- | ||
+16.30% | 5.25B | B- | ||
+2.20% | 4.1B | B | ||
-9.24% | 3.8B | B- | ||
-8.91% | 3.39B | B+ | ||
+7.27% | 3.25B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- UPR Stock
- Ratings Uniphar plc